Results 301 to 310 of about 2,726,696 (323)

Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection. [PDF]

J Infect Dis
Durkee-Shock J, Cohen A, Maghzian N, Pezzella G, Jensen-Wachspress M, Hostal A, Barton K, Gangler K, Dávila Saldaña BJ, Chaimongkol N, Bollard CM, Sosnovtsev SV, Cohen J, Nagata BM, Alves DA, Ghosh R, Seifert BA, Freeman A, Gonzalez C, Notarangelo LD, Green KY, Keller MD.   +21 more
europepmc   +1 more source

Abstract from 1970 [PDF]

, 1998
Starzl, TE
core  

Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error. [PDF]

Adv Biomed Res
Salemi N, Shojaie B, Bolourinejad P, Sherkat R, Zamanifar A, Ghaedrahmati F, Azizi M, Aria H.   +7 more
europepmc   +1 more source

Inborn errors of immunity in Canadian First Nations and Nunavut Inuit Children: the tip of the iceberg. [PDF]

Paediatr Child Health
Pham-Huy A, Murguia-Favela L, Rubin T, Suresh S, Wright NAM, Derfalvi B, Sinha R, Bowes J, Cuvelier GDE, Clinical Immunology Network-Canada (CINC) .   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.

Blood
HLA-mismatched transplants with either in vitro depletion of CD3+TCRαβ/CD19 (TCRαβ) cells or in vivo T-cell depletion using post-transplant cyclophosphamide (PTCY) have been increasingly used for patients with inborn errors of immunity (IEI).
S. Lum, Michael H. Albert, Patrick Gilbert, Tiarlan Sirait, M. Algeri, Rafaella Muratori, Benjamin Fournier, A. Laberko, M. Karakukcu, E. Unal, M. Ayas, S. Yadav, T. Fışgın, R. Elfeky, Juliana F Fernandes, M. Faraci, Theresa Cole, Ansgar S Schulz, Roland Meisel, M. Zecca, M. Ifversen, Alessandra Biffi, J. Diana, Tanja C Vallée, S. Giardino, G. Ersoy, D. Moshous, A. Gennery, D. Balashov, C. Bonfim, Franco Locatelli, A. Lankester, B. Neven, M. Slatter   +33 more
semanticscholar   +1 more source

Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy

Immunological Reviews
Inborn errors of immunity (IEI) present a unique paradigm in the realm of gene therapy, emphasizing the need for precision in therapeutic design. As gene therapy transitions from broad‐spectrum gene addition to careful modification of specific genes, the
Hana Y. Ghanim, Matthew H. Porteus
semanticscholar   +1 more source

Evolution of Gene Therapy for Inborn Errors of Immunity.

JAMA pediatrics
This Viewpoint reviews the history and current state of gene therapy for inborn errors of immunity.
I. Somekh, Ayal Hendel, R. Somech
semanticscholar   +1 more source

Inborn errors of immunity and invasive fungal infections: presentation and management

Current Opinion in Infectious Diseases
Purpose of review We review the clinical presentations of invasive fungal infections in a selection of inborn errors of immunity. In addition, we review the particularities of their management, including antifungal therapy, prophylaxis, and ...
O. Paccoud, A. Warris, A. Puel, F. Lanternier   +3 more
semanticscholar   +1 more source